It is clear, however, from all these recent studies, that SLC44A2 is an important target to consider for future therapeutic strategies against DVT and that its molecular function warrants further investigation to shed more light upon the intricate mechanisms involved in the initiation of DVT. Here, SLC44A2 is linked to deep vein thrombosis.